Skip to content
Homepage
Category:
Globe Newswire
Posted Date:
June 8, 2026
Realtek Joins OpenTitan Coalition to Develop Discrete Hardware Root of Trust Devices
LOWRISC C.I.C.
June 8, 2026
Copenhagen Infrastructure Partners partially divests 500MW Devilla BESS project to Scottish National Investment Bank and Nuclear Liabilities Fund
Copenhagen Infrastructure Partners
June 8, 2026
ING to appoint Andrea Cesaroni as chief risk officer
ING Group
June 8, 2026
Sterling Trading Tech Implements Revised FINRA Rule 4210 for Lightspeed Financial
Sterling Trading Tech
June 8, 2026
Reminder: Nicox June 2024 Warrants will expire June 19, 2026
NICOX SA
June 8, 2026
Bombardier and Elie Saab Debut First-of-its-kind Collaboration, Introducing the Haute Couture of Aviation with Bespoke Global 8000 Cabin Design
Bombardier Inc.
June 8, 2026
Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
Nurix Therapeutics, Inc.
June 8, 2026
Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
Sanofi Winthrop Industrie
June 8, 2026
WISeKey, The Hashgraph Group and Hedera Launch QAIT Q-Day Security Assessment Platform on the SEALCOIN Quantum Marketplace
Wisekey International Holding Ltd.
June 8, 2026
Toobit Adds XLM to Fixed Earn Series with Limited-Time 60% APR
Toobit
June 8, 2026
Lim Meng Hoong: AI Is Entering a New Era of Scientific Infrastructure, Insights from Science x AI Summit 2026
MengHoong Intelligent Investment Academy
June 7, 2026
Macau Tea Beverage Brand ‘Cha Yu’ Redefines Local Flavors with Original Recipes and Signature Cloud Milk Tea
Cha Yu Limited
June 7, 2026
GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
GNI Group Co., Ltd.
June 7, 2026
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
LENZ Therapeutics, Inc.
June 7, 2026
NVIDIA and SK hynix Announce Multiyear Technology Partnership to Advance Memory for AI Factories
NVIDIA
June 7, 2026
NAVER Expands AI Infrastructure With NVIDIA to Serve Surging Global AI Demand
NVIDIA
June 7, 2026
Entrata Collaborates with OpenAI to Define the Future of Autonomous Property Management
Entrata
June 7, 2026
SK Telecom and NVIDIA Build AI Infrastructure to Power Korea’s AI Innovation
NVIDIA
June 7, 2026
Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 Diabetes
Diasome
June 7, 2026
GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders
GoHealth, Inc.
June 7, 2026
Zealand Pharma announces Boehringer Ingelheim’s survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
Zealand Pharma
June 7, 2026
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
Boehringer Ingelheim Limited
June 7, 2026
Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist
Antag Therapeutics
June 7, 2026
Prev
1
…
372
373
374
